A model for the Dutch pharmaceutical market
โ Scribed by Erik Canton; Ed Westerhout
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 103 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1057-9230
No coin nor oath required. For personal study only.
โฆ Synopsis
This paper develops a general-equilibrium model for the Dutch pharmaceutical market. The model derives the behaviour of patients, pharmacists, drug producers and parallel-importers from microeconomic principles and recognizes the interactions between the various actors. The latter is important since the general-equilibrium effects are sometimes at odds with intuition from a partial-equilibrium approach. A calibrated version of the model is used to evaluate the effects of various policy experiments on the bill for pharmaceutical care in the Netherlands. These experiments include an incentive policy to encourage cost-conscious drug distribution, an increase of copayments for pharmaceutical care, a reduction of trade barriers for parallel-importers, and market entry by producers of generic substitutes.
๐ SIMILAR VOLUMES
In this paper, we describe the Dutch pharmaceutical market, which is heavily regulated by the government. Through the regulation of prices and promoting prudent use, the Dutch government tries to bring down the cost of pharmaceuticals, which increases every year at a higher rate than total health ca
The Nutrient Flow Model (NFM) is a micro-simulation model. It describes economic activities and corresponding nutrient flows at farm level for present and future situations in which environmental policy measures are taken. The farm results are aggregated to regional and national levels. The model ca